COVID-19 Associated Lymphopenia Pathogenesis Study in Blood | MicrobiomeTrials← Back to trialsNCT04401436
COVID-19 Associated Lymphopenia Pathogenesis Study in Blood
CompletedOBSERVATIONAL
Trial Details
Start: 2020-05-22Est. Completion: 2025-02-20
Enrollment target: 240 participants Locations- MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
- MedStar Health Research Institute: Washington Hospital Medical Center, Washington D.C., District of Columbia, United States
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
FibromyalgiaFibromyalgia, Primary
This study is a randomized, single-blinded, parallel, superiority, controlled trial. The main objective is to verify the…
Pelotas, BrazilCompleted Jan 7, 2022
Chronic Kidney Disease Stage 5End Stage Renal Disease
The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care wi…
Winnipeg, CanadaEst. completion Mar 30, 2027
Recruiting
Total knee replacement (TKR) is a successful and cost-effective treatment for end-stage arthritis. Its usage is increasi…
Leeds, United KingdomEst. completion Sep 1, 2026